Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

Authors
Publication date
1 January 2016
Publisher
'Oxford University Press (OUP)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1093%2Fannonc%2Fmd...
      Last time updated on 05/06/2019

      University of Southern Denmark Research Output

      redirect
      oaioai:pure.atira.dk:publications...
      Last time updated on 13/04/2017

      VBN

      redirect
      oaioai:pure.atira.dk:publications...
      Last time updated on 14/04/2017